Lemborexant API: Formulation Considerations for Effective Insomnia Treatments Insomnia, the struggle to fall asleep or stay asleep, disrupts millions of lives worldwide. Lemborexant, a new class of medication known as dual orexin receptor antagonists (DORAs), has emerged as a promising treatment option. However, for this promise to be fully realized, pharmaceutical companies must address critical formulation considerations surrounding the Lemborexant Active...
0 Shares
610 Views
0 Reviews